Cardiovascular Advances in Research and Opportunities Legacy Act
Dec 20, 2022
Statute: 136 Stat. 2340
Became law: Dec 20, 2022
Dec 20, 2022
Statute: 136 Stat. 2340
Became law: Dec 20, 2022
Summary
Creates a program to research valvular heart disease to better understand its causes, risk factors, and how to prevent sudden death from the condition.
What problem does this solve?
Valvular heart disease is not well understood, and it can lead to sudden cardiac death without warning. This law provides money for research and education to learn more about the disease and help prevent these deaths.
What does this law do?
Authorizes funding for heart disease research
Provides $28 million for each fiscal year from 2023 through 2027 to carry out research and awareness activities for valvular heart disease.
Establishes a new research program
Directs the National Institutes of Health (NIH) to support or conduct research on valvular heart disease, in partnership with the National Heart, Lung, and Blood Institute.
Requires a workshop on mitral valve prolapse
Orders the National Heart, Lung, and Blood Institute to hold a workshop with experts within two years to identify research needs for treating mitral valve prolapse.
Funds public awareness campaigns
Allows the Secretary of Health and Human Services to award grants to public or nonprofit groups to increase education and awareness about valvular heart disease.
Prioritizes grants for high-risk groups
Gives priority for awareness grants to organizations that plan to help populations most affected by valvular heart disease.
Who does this affect?
- People with or at risk of valvular heart disease
- Medical researchers and cardiologists
- Public health organizations
What is the real world impact?
•
Reduces deaths from a specific heart condition
Aims to prevent sudden cardiac deaths by funding new research into valvular heart disease. By understanding the causes and risk factors better, doctors can identify and treat at-risk patients before a fatal event occurs.
When does this start?
This law became effective on December 20, 2022, and includes a specific deadline for future action.
Mitral valve prolapse workshop
A workshop to identify research needs for mitral valve prolapse must be held by December 20, 2024.